Log In
Print
BCIQ
Print
Print this Print this
 

ASP015K

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionOral janus kinase-1 (JAK-1) inhibitor
Molecular Target Janus kinase-1 (JAK-1)
Mechanism of ActionJanus kinase-1 (JAK-1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today